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Identity 
Other names: CYP8; CYP8A1; EC 5.3.99.4; 
MGC126858; MGC126860; PGIS; PTGI 




64297 bases (chr20:47553818-47618114); 10 exons; 
telomere to centromere orientation. 
Transcription 
Two alternative splicing products; 5624bp (coding, 
1578bp ORF) and 313bp (non-coding). A 1.5kb 
upstream sequence presents CG-rich and pyrimi-dine-
rich regions and contains consensus sequences for the 
recognition sites of Sp-1, AP-2, INF-gamma responsive 
element, GATA, NF-kB, glucocorticoid responsive 
element and a CACCC box. 
It has been demonstrated that PTGIS transcription is 
regulated via Sp1 binding, which may affected by 
polymorphisms in the promoter region. The CG-rich 
region presents significant promoter activity. 
 
Map of 20q13 chromosomal region. 
 
 
Schematic diagram of PTGIS genomic region. 
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PTGIS is a protein from the cytochrome P450 
superfamily that consists of 500 amino acids and has a 
molecular weight of 57kDa. Is a single-pass membrane 
protein with a single transmembrane domain (1-20) and 
presents a heme-binding site at position 441. No post-
translational modifications have been described for this 
protein. 
Expression 
Abundant in heart, lung, skeletal muscle, ovary and 
prostate. PTGIS is found underexpressed in most 
colorectal carcinomas and in several lung carcinomas 
and hypertensive subjects. 
Localisation 
At cellular level can be found in the endoplasmatic 
reticulum membrane and in microsomes as a peripheral 
membrane protein. 
Function 
Catalyses the isomerization of prostaglandin H2 to 
prostacyclin (prostaglandin I2), a potent vasodilator 
and inhibitor of platelet aggregation. 
Homology 
Pan troglodytes - Prostaglandin I2 (prostacyclin) 
Synthase. 
Canis lupus familiaris - Prostaglandin I2 (prostacyclin) 
Synthase. 
Bos taurus - Prostaglandin I2 (prostacyclin) Synthase. 
Mus musculus - Prostaglandin I2 (prostacyclin) 
Synthase. 
Rattus norvegicus - Prostaglandin I2 (prostacyclin) 
Synthase. 









PTGIS promoter is silenced by through promoter 
hypermethylation in a large subset of colorectal 
carcinomas (also observed in colorectal adenomas and 
in several colorectal cancer cell lines). The PTGIS 
silencing is an early event on tumor progression and
age and sex-independent. A PTGIS promoter VNTR 
polymorphism has been associated with the risk of 
colorectal polyps, being the risk increased when both 
alleles present less than 6 repeats. 
Non-small cell lung cancer 
Disease 
PTGIS promoter is hypermethylated in lung cancer cell 
lines. The VNTR polymophism has also been 
associated with gene silencing in lung cancer cells. 
Breast cancer 
Disease 
The combination of the SNPs PTGIS(11)rs477627, 
PTGIS(21)rs476496 and PTGIS(20)rs1066894, located 
in the 5' region and first intron, confers reduced 
susceptibility to breast cancer. 
Essential hypertension 
Disease 
A splicing mutation (T->C at the +2 position of the 
donor site of the intron 9) alters the reading frame and 
results in the production of a truncated protein with the 
heme-binding region deleted. The subjects found with 
this mutation presented lower levels of prostacyclin and 
hypertension. 
The polymorphism C1117A has been significantly 
associated with hypertension, being the allele C 
associated with higher risk the condition, although it 
does not change the aminoacid sequence. 
A polymorphism in the 5' region with a variable 
number of repeats of a 9-bp sequence (CCGCCAGCC) 
is associated with hypertension. The alleles less rpeats 
possess less Sp1 sites and present lower promoter 
activity, being related with  
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higher pulse pressure in women and higher systolic 
blood pressure in older individuals. 
Cerebral infarction 
Disease 
Association between cerebral infarction and the PTGIS 
promoter VNTR alleles with less repeats. 
Myocardial infarction 
Disease 
A synonymous SNP at codon 373 (Arg373Arg) in exon 
8 has been associated with risk of myocardial infarction 
in the japanese population. 
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